Zymo Drug Kills Hep C Virus

4/24/09

ZymoGenetics (NASDAQ: ZGEN), a Seattle biotech company, and partner Bristol-Myers Squibb said today that a drug they are co-developing for hepatitis C was able to kill the virus with minimal side effects in a small four-week study. The trial looked at pegylated interferon lambda on its own, or in combination with a standard ribavirin treatment. The full data was presented at the European Association for the Study of the Liver meeting in Copenhagen, Denmark.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @

Next Post

Related Topics

Related Posts

  • Pingback: Medical homes movement may reach critical mass in Michigan — MedCity morning read, April 24 : MedCity News

  • deborah anderson

    help me

  • http://xconomyseattle larry yarbrough

    I do hope this treatment works and it’s on the market soon. The side effects
    of current treatment of pegintron nearly killed my wife.

  • http://statins.org Ray Patterson

    Please help me. I could not complete the standard treatment because of the nasty side effects. It almost killed me. I will volunteer to be a test subject for this promising new drug. Please help.

    Ray Patterson
    rptexas@gmail.com

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    Ray—you can find more information about an ongoing clinical trial of the ZymoGenetics drug at this link below.

    http://clinicaltrials.gov/ct2/show/NCT01001754?term=IL-29&rank=2

  • carmelo rolon

    Well I’m currently on Peginterferon alfa-2a which is used in combination with another drug called Copegus(Ribavirin).The side-effect wasn’t so bad,like I was told they would be. But anyways, I was reading about this drug thats being co-developed called Zymo. I believe that this is wonderful and I hope they hurry up with it so I can get rid of this terrible virus thats living inside of me. But if not I have my hopes high that the interferon that I’m on will cure me. It’s a whole year treatment, but I have patience. I’m so bless to know that theres really good treatment out there for me. Now it’s time to get something for cancer!

  • I. Biberstein

    Dr. Timmerman: It’s great to know that there is a hope for killing this stubbern virus with less side effect. We are in Canada and my husband is stage 2. His doctor suggest he go for the treatment sooner than later. Is it possible for Canadian to participate in this study? How can he participate in the Clinical study

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    I. Biberstein—thanks for the salutation, but I’m not a medical doctor, and not qualified to give medical advice. I do see a current Phase 2 trial of pegylated interferon lambda that’s recruiting 55 patients, at sites in Texas and Puerto Rico (link below). I’ll check with the company to see if there are other sites open that might be more close to you in Canada. You’ll have to ask your doctor if your husband might be a candidate for this trial.

    http://www.clinicaltrials.gov/ct2/show/NCT01001754?term=pegylated+interferon+lambda&rank=2

  • shahbaz ahmed

    i am patient of anti hcv for the last ten years living in saudi arabia
    please tell me what to do.i am taking only liv 52 DS
    shahbaz ahme

  • Lori

    I was recently diagnoised with Hep C- Geno-type 1 in August. Please tell me if there is a clinical trial in California I could get on for this cure. I am determined to fight this disease.

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.